Table 3.
Other metastasis after pancreatic metastasis and long-term outcome
| Case no. | Recurrence or metastasis after pancreatic resection | Postoperative observation period (months) | |
|---|---|---|---|
| Location | Treatment | ||
| 1 | Bilateral lung | None (BSC) | 131a |
| 2 | Bilateral lung | IFN + IL-2 + UFT | 108a |
| 3 | – | – | 138 |
| 4 | – | – | 49 |
| 5 | Bilateral lung | Sunitinib | 8 |
| 6 | – | – | 8 |
| 7 | – | – | 3 |
| 8 | – | – | 39 |
| 9 | Bilateral lung, bone | Dacarbazine | 4a |
Postoperative observation period months after the operation for the pancreatic metastasis, BSC best supportive care, IFN interferon, IL-2 interleukin-2, UFT tegafur-uracil
aDead